Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Eledon Pharmaceuticals Inc
2TKCurrent price
4.42 EUR
-0.081 EUR (-1.78%)
Last closed
4.27 USD
Company
eledon.com
ISIN
US28617K1016
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
288 540 800 USD
Yield for 12 month
+230.40 %
1Y
3Y
5Y
10Y
15Y
2TK
Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. The company uses its immunology expertise in targeting the CD40 Ligand (CD40L, also called CD154) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential. It is also developing its products for kidney transplantation, xenotransplantation, and liver transplantation. The company has a collaboration agreement with eGenesis, Inc. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California. Address: 19900 MacArthur Boulevard, Irvine, CA, United States, 92612
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
14 USDP/E ratio
10.7333Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
+560 000 USD
Last Quarter
–
Current Year
-374 000 USD
Last Year
-373 000 USD
Current Quarter
-97 000 USD
Last Quarter
-95 000 USD
Key Figures 2TK
1 year
3 years
5 years
10 years
EBITDA
-36 862 000 USD
Operating Margin TTM
PE Ratio
10.7333
Return On Assets TTM
-25.8 %
PEG Ratio
–
Return On Equity TTM
-237.39 %
Wall Street Target Price
14 USD
Revenue TTM
–
Book Value
-0.22 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
0.45 USD
Diluted Eps TTM
0.45 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 2TK
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 2TK
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:18
Payout Ratio
–
Last Split Date
05.10.2020
Dividend Date
05.10.2020
Stock Valuation 2TK
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
10.7333
Forward PE
5.3908
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
0.8366
Price Book MRQ
1.3072
Financials 2TK
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 2TK
For 52 weeks
1.11 USD
5.54 USD
50 Day MA
3.08 USD
Shares Short Prior Month
118 633
200 Day MA
2.5 USD
Short Ratio
2.2
Shares Short
142 854
Short Percent
0.41 %
BeatStart